The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Subscribe To Our Newsletter & Stay Updated
